Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE study experience
Authors:
- Barry R. DavisBDBarry R. Davis
- Arthur RibaARArthur Riba
- Lemuel A. MoyeLMLemuel A. Moye
- Chuan-Chuan WunCWChuan-Chuan Wun
- Jean L. RouleauJRJean L. Rouleau
- Gervasio A. LamasGLGervasio A. Lamas
- Marc A. PfefferMPMarc A. Pfeffer
- 1 March 1998
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 135 (3) , 406-413
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Calcium antagonists and mortality in patients with coronary artery disease: A Cohort study of 11,575 patientsJACC, 1996
- A delayed answer to the calcium blocker questionJACC, 1996
- Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.Heart, 1995
- Rationale, design and baseline characteristics of the survival and ventricular enlargement trialThe American Journal of Cardiology, 1991
- Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studiesThe American Journal of Cardiology, 1991
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981